IP Library Granted Patent US 8,246,909
Granted Patent B2
US 8,246,909 · App. 11/855,291 · Granted Aug 21, 2012

Automated endoscope reprocessor germicide concentration monitoring system and method

Assignee: Ethicon, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,246,909
App. No.
11/855,291
Granted
Aug 21, 2012
Kind
B2
Abstract

A method measures a property of a germicidal solution in an endoscope processor spectroscopically by placing a quantity of the solution into a cuvette and passing a light therethrough. A reservoir receives a quantity of the solution and bubbles are filtered out via a cross-flow filter prior to putting a sample therefrom into the cuvette for measuring.

Claims (37)

1. A method for measuring concentration of a germicide in an instrument processor, the method comprising the steps of:

directing a flow of fluid containing the germicide through a bubble filter to obtain a bubble free sample of the fluid;

directing the sample of the fluid into a sample chamber having clear sides;

passing light of a known intensity and wavelength through the chamber and sample;

detecting the light passing therethrough with a sensor; and

determining a concentration of the germicide in the sample;

wherein the bubble filter comprises a bubble outlet vent, a membrane, and a cross-flow filter wherein the flow of fluid passes along the membrane and a portion of the flow passes through the bubble outlet vent providing the sample and preventing the accumulation of bubbles against the membrane, the bubbles carried out through the bubble outlet vent.

2. The method according to claim 1 wherein the germicide comprises orthophthalaldehyde.

3. The method according to claim 2 wherein the light is at about 254 nm.

4. The method according to claim 3 wherein at least 90 percent of the light's spectra is within 450 nm plus or minus 1 nm.

5. The method according to claim 1 wherein the membrane is hydrophilic and has a maximum pore size of 0.2 μm.

6. The method according to claim 5 wherein the membrane has a maximum pore size of 0.45 μm.

7. The method according to claim 1 and further comprising the step of aborting an instrument processing cycle in the instrument processor if the concentration is below a predetermined level.

8. The method according to claim 7 wherein the germicide comprises orthophthalaldehyde and the predetermined level is 0.059% or lower.

9. The method according to claim 1 wherein the germicide comprises orthophthalaldehyde, wherein the method further comprises the step of aborting an instrument processing cycle in the instrument processor if the concentration is above 0.1%.

10. The method according to claim 1 wherein the germicide comprises orthophthalaldehyde, wherein the method further comprises the step of aborting an instrument processing cycle in the instrument processor if the concentration is above 0.85%.

11. The method according to claim 1 wherein the flow of fluid passing along the membrane carries bubbles away from an upstream side of the membrane.

12. The method of claim 1 , wherein the bubble outlet vent is permanently maintained in the permanent open position.

13. An instrument processor comprising:

an enclosure for holding an instrument;

a fluid distribution system for delivering a fluid containing a germicide to the instrument within the enclosure;

a germicide concentration measuring subsystem comprising:

a bubble filter connected to the fluid distribution system;

a sample chamber connected to a sample outlet of the bubble filter;

a light source for passing a light of known intensity and wavelength through a sample of the fluid in the sample chamber;

a sensor for measuring light passing through the sample;

a control system for determining the concentration of the germicide in the sample based upon the light arriving at the sensor;

wherein the bubble filter comprises a bubble outlet vent, a membrane, and a cross-flow filter wherein a flow of fluid passes along the membrane and a portion of the flow passes through the bubble outlet vent providing the sample and preventing the accumulation of bubbles against the membrane, the bubble outlet vent configured to carry bubbles therethrough.

14. The instrument processor according to claim 13 wherein the germicide comprises ortho-phthalaldehyde.

15. The instrument processor according to claim 4 wherein the light is at about 254 nm.

16. The instrument processor according to claim 5 wherein at least 90 percent of the light's spectra is within 254 nm plus or minus 1 nm.

17. The instrument processor according to claim 15 wherein the germicide comprises ortho-phthalaldehyde and the predetermined level is 0.059% or lower.

18. The instrument processor according to claim 13 wherein the membrane is hydrophilic and has a maximum pore size of 0.2 μm.

19. The instrument processor according to claim 18 wherein the membrane has a maximum pore size of 0.45 μm.

20. The instrument processor according to claim 13 and further comprising the control system being programmed to abort an instrument processing cycle in the instrument processor if the concentration is below a predetermined level.

21. The instrument processor according to claim 13 wherein the germicide comprises ortho-phthalaldehyde, wherein the control system is programmed to abort an instrument processing cycle in the instrument processor if the concentration is above 0.1%.

22. The instrument processor of claim 13 , wherein the bubble outlet vent is permanently maintained in the permanent open position.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2019
From: ETHICON, INC.
To: ASP GLOBAL MANUFACTURING GMBH
Reel/Frame 050730/0209 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2007
From: WILLIAMS, HAL; FANG, YAN; JACKSON, RICHARD
To: ETHICON, INC.
Reel/Frame 020136/0337 →
Continuity (1)
Related Publication 20090060798A1 · Mar 5, 2009